Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study
2005 ◽
Vol 22
(11)
◽
pp. 1574-1580
◽
2005 ◽
Vol 49
(10)
◽
pp. 4386-4389
◽
2020 ◽
Vol 0
(0)
◽
pp. 0-0
1999 ◽
Vol 84
(10)
◽
pp. 3485-3489
◽
Keyword(s):